Author

M. Touat

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

K. L. Ligon· 2 shared P. Y. Wen· 2 shared A. S. Kim· 1 shared C. C. Ritch· 1 shared C. Yapp· 1 shared J. C. Yoon· 1 shared J. Geduldig· 1 shared J. Hwang· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

K. L. Ligon

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single Cell Spatial Analysis Reveals the Topology of Immunomodulatory Purinergic Signaling in Glioblastoma

S. Coy, S. Wang, S. A. Stopka, J.-R. Lin, R. Rashid, C. Yapp, C. C. Ritch, P. Khadka, M. Regan, J. Hwang, P. Y. Wen, P. Bandopadhayay, K. L. Ligon, N. Y. Agar, P. K. Sorger, , S. Santagata

The paper uses spatial single-cell analysis to show that CD73 and CD39 expression in glioblastoma correlates with poor clinical outcomes and immunosuppressive signaling.

bioRxiv · Jan 12, 2022Cancer Biology

Functional drug susceptibility testing based on biophysical measurements predicts patient outcome in glioblastoma patient-derived neurosphere models

M. A. Stockslager, S. Malinowski, M. Touat, J. C. Yoon, J. Geduldig, M. Mirza, A. S. Kim, P. Y. Wen, K.-H. Chow, K. L. Ligon, S. R. Manalis

Using biophysical assays on glioblastoma patient-derived neurosphere models, the study finds that ex vivo drug susceptibility testing predicts patient survival with similar accuracy to MGMT promoter methylation.

bioRxiv · Aug 5, 2020 · PreprintCancer Biology